Addus HomeCare (ADUS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
19 May, 2026Executive summary
Net service revenues rose 7.7% year-over-year to $363.6 million for Q1 2026, driven by growth in personal care and hospice segments, partially offset by a decline in home health revenues.
Net income increased 18.1% to $25.1 million, with adjusted EPS up 14.1% to $1.62 and adjusted EBITDA up 9.7% to $44.5 million.
Cash flow from operations was $52.4 million, with cash on hand of $103.1 million and reduced bank debt to $94.3 million.
Closed acquisition of HomeCourt Home Care in Indiana and signed a definitive agreement for another Indiana acquisition, both expected to be immediately accretive.
Growth supported by positive hiring trends, operational improvements, and favorable reimbursement rate changes in key states.
Financial highlights
Personal care segment revenue grew 8.8% to $281.1 million (77.3% of total revenue), with 6.5% organic growth and higher revenue per billable hour.
Hospice revenue was $65.8 million (18.1% of revenue), with 7.7% organic growth and improved average daily census.
Home health revenue was $16.7 million (4.6% of revenue), with improved operating income despite a year-over-year revenue decline.
Gross margin remained stable at 31.9% year-over-year; adjusted EBITDA margin was 12.2%.
Adjusted net income per diluted share was $1.62, excluding $0.06 in acquisition expenses and $0.20 in non-cash stock-based compensation.
Outlook and guidance
Expect gross margin and adjusted EBITDA margin to remain stable and above 12% for the full year.
Anticipate continued growth in personal care and hospice, with same-store personal care hours per business day targeted at 2–2.5%.
Home health expected to return to growth in the second half of 2026, supported by new leadership and sales initiatives.
Management expects continued organic growth and value from acquisitions in 2026, with optimism for further expansion and synergies across care segments.
Targeting at least 10% annual revenue growth, benefiting from demographic trends and managed care expansion.
Latest events from Addus HomeCare
- PCS growth, tech adoption, and M&A drive expansion amid stable regulatory and financial outlook.ADUS
RBC Capital Markets Global Healthcare Conference 202624 May 2026 - Census and hours growth accelerate with tech adoption, supporting balanced expansion and M&A.ADUS
Bank of America Global Healthcare Conference 202613 May 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.ADUS
Proxy filing23 Apr 2026 - Achieved $1.4B revenue in 2025 with strong growth, stable margins, and expanding national footprint.ADUS
Investor presentation23 Apr 2026 - Hospice recovery, census growth, and tech-driven hiring fuel expansion amid stable rates.ADUS
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Strong Q4 exit, tech-driven efficiency, and robust growth outlook amid regulatory changes.ADUS
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - Margins, growth, and M&A drive performance as census rebounds and tech boosts fill rates.ADUS
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Q4 2025 revenue and EBITDA surged, led by personal care and hospice growth.ADUS
Q4 202524 Feb 2026 - Growth driven by acquisitions, tech, and value-based care, with census recovery expected by 2026.ADUS
Jefferies 2025 Healthcare Services Conference3 Feb 2026